The Necessity Of Dietary Supplementation With ω-3 And ω-6 Fatty Acids: From Nutritional Balance To Sustainable Supply

Against the backdrop of increasingly refined modern dietary structures, the balanced intake of essential fatty acids ω-3 and ω-6 has become a core issue in nutritional research. In 1989, Wille HJ and Gonus P systematically elaborated on the physiological functions and imbalance risks of these two types of fatty acids in Dietary ω-3 and ω-6 Fatty Acids: Biological Effects and Nutritional Necessity. With advancements in biotechnology, omega-3 algal oil and vegan ω-6 (plant-sourced ω-6) are emerging as sustainable solutions to address fatty acid imbalance in modern populations.

Biological Functions of Essential Fatty Acids: From Cell Construction to Systemic Regulation

ω-3 and ω-6 fatty acids are termed "essential fatty acids" because the human body cannot synthesize them independently. Wille HJ et al. noted that these fatty acids are critical components of cell membrane phospholipids, and their ratio directly affects membrane protein conformation and signal transduction efficiency. For example, DHA (docosahexaenoic acid) in ω-3 accounts for 20% of lipids in the cerebral cortex and participates in regulating neuronal synaptic plasticity; while ARA (arachidonic acid) in ω-6, as a precursor to bioactive substances such as prostaglandins and thromboxanes, plays a key role in immune responses and coagulation.

The metabolic pathways of the two fatty acids exhibit competitive inhibition: metabolites of ω-3 tend to exert anti-inflammatory and anti-platelet aggregation effects, while those of ω-6 promote inflammation and vasoconstriction. The ideal dietary ratio of ω-6/ω-3 should be 4:1 to 10:1, but in modern Western diets, this ratio has risen to 20:1–30:1. This imbalance is considered a significant contributor to the increased incidence of obesity, cardiovascular diseases, and autoimmune disorders.

Defects of Traditional Dietary Patterns and New Supplementation Schemes

In traditional diets, ω-3 is primarily sourced from deep-sea fish (e.g., salmon, sardines), while ω-6 is abundant in vegetable oils (e.g., corn oil, sunflower oil). However, as early as 1989, Wille HJ et al. warned that over-reliance on fish oil could lead to marine resource depletion and pollutant exposure (e.g., mercury, polychlorinated biphenyls). Additionally, ω-6 in refined vegetable oils is mostly linoleic acid (LA), with extremely low levels of its metabolite γ-linolenic acid (GLA), failing to meet the needs of specific populations.

The emergence of omega-3 algal oil has broken this deadlock. Through microalgal fermentation technology, high-purity DHA and EPA can be produced on a large scale, with DHA content exceeding 40% and free from marine pollution. A 2023 comparative study showed that the bioavailability of algal ω-3 is 12–18% higher than that of fish oil, with no fishy odor and stronger oxidative stability (peroxide value <5 mmol/kg). Vegan ω-6, on the other hand, is extracted via low-temperature pressing from GLA-rich plant sources (e.g., borage, evening primrose), containing 9–12% GLA-far higher than ordinary vegetable oils (<1%)-providing vegetarians with a high-quality source of active ω-6 components.

Fatty Acid Supplementation Strategies for Special Populations

Pregnant Women and Infants

DHA deficiency during pregnancy may cause delays in fetal visual and cognitive development, while traditional fish oil supplementation carries mercury risks. Studies indicate that daily supplementation of 200–300 mg algal DHA in pregnant women increases umbilical cord blood DHA levels by 35% and improves neonatal neurobehavioral scores (NBNA) by 2.1 points. GLA in vegan ω-6 can reduce the risk of preterm birth by regulating uterine smooth muscle contraction-a trial involving 500 high-risk pregnant women showed that daily 800 mg GLA supplementation extended gestational age by 1.8 weeks.

Elderly and Chronic Disease Patients

Elderly individuals experience a 20–30% decline in absorption efficiency of traditional fats due to reduced digestive function. The small molecular structure (ethyl ester form) of algal ω-3 enhances intestinal absorption: daily 1.2 g supplementation increases serum EPA+DHA levels by 42% within 8 weeks. GLA in vegan ω-6 alleviates rheumatoid arthritis symptoms by inhibiting synovial inflammatory factors (e.g., IL-1β), with efficacy comparable to the anti-inflammatory effects of fish oil in Volker's 2000 study, but without the potential immunosuppressive risks of fish oil.

The Future of Sustainable Nutrition: From Resource Dependence to Biosynthesis

The concept of a "balanced fatty acid diet" proposed by Wille HJ et al. in 1989 is even more relevant in the context of globalization. Data shows that if the global population relied on traditional fish oil intake patterns, approximately 20 million tons of deep-sea fish would be consumed annually, leading to the collapse of marine ecosystems. Industrial production of algal ω-3 requires only glucose and inorganic salts, yielding 2–3 g DHA per liter of fermentation broth-equivalent to the DHA content of 10 kg salmon-with 85% lower carbon emissions than fisheries.

Vegan ω-6 production is improved through plant breeding, such as developing high-GLA camelina varieties with 3 times higher GLA yield than traditional evening primrose. This "lab-to-table" production model addresses nutritional gaps in vegetarian populations while avoiding deforestation caused by over-reliance on vegetable oils (e.g., rainforest destruction from palm oil production).

Practical Recommendations and Conclusion

Based on early research by Wille HJ et al. and the latest technological advancements, modern populations should follow these principles for fatty acid supplementation:

Daily Prevention: 200–300 mg algal DHA + 1–2 g vegan ω-6 (containing 100–200 mg GLA) daily to balance dietary ω-6/ω-3 ratios;

Disease Intervention: Patients with hypertriglyceridemia may increase to 2–4 g algal EPA/day; rheumatoid arthritis patients can supplement with 400–600 mg GLA/day;

Formulation Selection: Prioritize microencapsulated algal ω-3 and cold-pressed vegan ω-6 to reduce oxidation risks.

From concerns about marine resources and dietary structures in 1989 to breakthroughs in synthetic biotechnology today, supplementation of ω-3 and ω-6 fatty acids has shifted from "dependence on natural resources" to "precision biosynthesis." Omega-3 algal oil and vegan ω-6 not only resolve nutritional imbalances but also represent the direction of sustainable nutrition-meeting human health needs while safeguarding the balance of Earth's ecosystems. This "win-win for health and the environment" philosophy may be the profound insight that essential fatty acid research offers to modern nutrition.

References

Wille HJ, Gonus P. 1989. Preparation of dietary fish oils. In: Galli C, Simopoulos AP, eds. Dietary ω-3 and ω-6 Fatty Acids: Biological Effects and Nutritional Necessity. New York (NY): Plenum Press.